Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,1641912,Alcrsp18,Alcohol response QTL 18,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),5,35788756,147487820,Rat,n/a,region,qtl 1000,1641903,Alcrsp3,Alcohol response QTL 3,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),5,13288888,58288888,Rat,n/a,region,qtl 1000,1641922,Alcrsp8,Alcohol response QTL 8,,,alcohol metabolism trait (VT:0015089),blood ethanol level (CMO:0000535),5,35788756,70742105,Rat,n/a,region,qtl 1000,1600376,Arunc5,Aerobic running capacity QTL 5,,0.21,exercise endurance trait (VT:0002332),maximum distance run on treadmill (CMO:0001406),3,78700444,123700444,Rat,n/a,region,qtl 1000,2293666,Bmd38,Bone mineral density QTL 38,4.4,,femur size trait (VT:1000369),femoral neck cortical cross-sectional area (CMO:0001702),5,8632285,53632285,Rat,n/a,region,qtl 1000,631649,Bp123,Blood pressure QTL 123,3.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,94788365,139788365,Rat,n/a,region,qtl 1000,1358885,Bp251,Blood pressure QTL 251,3.8,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,1358888,Bp264,Blood pressure QTL 264,4.43,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,7387306,Bw124,Body weight QTL 124,3.2,0.0003,body mass (VT:0001259),body weight (CMO:0000012),3,88910015,133910015,Rat,n/a,region,qtl 1000,8694437,Bw167,Body weight QTL 167,22.46,0.001,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),3,97009185,142009185,Rat,n/a,region,qtl 1000,12879848,Bw181,Body weght QTL 181,,0.015,body mass (VT:0001259),body weight (CMO:0000012),3,72672290,127023997,Rat,n/a,region,qtl 1000,1582219,Bw63,Body weight QTL 63,3.8,0.001,body mass (VT:0001259),body weight (CMO:0000012),3,100730984,119830094,Rat,n/a,region,qtl 1000,1582216,Bw65,Body weight QTL 65,6.3,,body mass (VT:0001259),body weight (CMO:0000012),3,106900427,119830094,Rat,n/a,region,qtl 1000,1582238,Bw68,Body weight QTL 68,3.2,0.0064,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,1582210,Bw71,Body weight QTL 71,3.3,0.0012,body mass (VT:0001259),body weight (CMO:0000012),3,66711607,119830094,Rat,n/a,region,qtl 1000,1582218,Bw74,Body weight QTL 74,3.9,0.0021,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,631665,Bw8,Body weight QTL 8,5.5,,body mass (VT:0001259),body weight (CMO:0000012),3,51821836,124513579,Rat,n/a,region,qtl 1000,2301970,Bw81,Body weight QTL 81,5.19,,body mass (VT:0001259),body weight (CMO:0000012),3,43295930,163640485,Rat,n/a,region,qtl 1000,2312670,Bw94,Body weight QTL 94,,0.01,inguinal fat pad mass (VT:0010424),inguinal fat pad weight to body weight ratio (CMO:0001253),3,103141814,176418101,Rat,n/a,region,qtl 1000,70216,Cm14,Cardiac mass QTL 14,2.1,,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,30846101,172879276,Rat,n/a,region,qtl 1000,724532,Cm17,Cardiac mass QTL 17,2,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),3,101058963,146058963,Rat,n/a,region,qtl 1000,1581503,Cm58,Cardiac mass QTL 58,2.7,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,45406058,127023997,Rat,n/a,region,qtl 1000,2301971,Cm71,Cardiac mass QTL 71,4.63,,heart left ventricle mass (VT:0007031),heart left ventricle weight (CMO:0000776),3,43295930,163640485,Rat,n/a,region,qtl 1000,1354611,Despr2,Despair related QTL 2,3.03,0.0028,locomotor behavior trait (VT:0001392),amount of time spent in voluntary immobility (CMO:0001043),3,102466149,147466149,Rat,n/a,region,qtl 1000,7394712,Emca13,Estrogen-induced mammary cancer QTL 13,,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,9514842,103580403,Rat,n/a,region,qtl 1000,1559282,Emca5,Estrogen-induced mammary cancer QTL 5,3.9,,mammary gland integrity trait (VT:0010552),percentage of study population developing mammary tumors during a period of time (CMO:0000948),3,45406058,177699992,Rat,n/a,region,qtl 1000,1582239,Epfw1,Epididymal fat weight QTL 1,4.5,0.0006,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),3,54630948,119830094,Rat,n/a,region,qtl 1000,2292613,Ept16,Estrogen-induced pituitary tumorigenesis QTL 16,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,1358186,Ept2,Estrogen-induced pituitary tumorigenesis QTL 2,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,2292591,Esta4,Estrogen-induced thymic atrophy QTL 4,,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),3,48561928,155263151,Rat,n/a,region,qtl 1000,1576314,Eutr1,Estrogen induced uterine response QTL 1,,,uterus integrity trait (VT:0010575),pyometritis severity score (CMO:0002009),5,1525098,78720537,Rat,n/a,region,qtl 1000,1576317,Eutr2,Estrogen induced uterine response QTL 2,,0.01,uterus integrity trait (VT:0010575),pyometritis severity score (CMO:0002009),5,35225432,108092802,Rat,n/a,region,qtl 1000,1598807,Glom12,Glomerulus QTL 12,2.7,,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),5,34402409,79402409,Rat,n/a,region,qtl 1000,2302273,Gluco35,Glucose level QTL 35,5.3,0.001,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,83817637,119509260,Rat,n/a,region,qtl 1000,2302373,Gluco39,Glucose level QTL 39,5.01,,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),3,103141944,170934860,Rat,n/a,region,qtl 1000,2316959,Gluco59,Glucose level QTL 59,4.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),5,35661945,117554267,Rat,n/a,region,qtl 1000,737818,Hcar12,Hepatocarcinoma resistance QTL 12,2.6,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),3,30114912,123700444,Rat,n/a,region,qtl 1000,1300117,Hrtrt8,Heart rate QTL 8,3.49,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),5,3251329,48722188,Rat,n/a,region,qtl 1000,2293087,Iddm27,Insulin dependent diabetes mellitus QTL 27,2.68,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,102152812,155263151,Rat,n/a,region,qtl 1000,1582221,Kidm30,Kidney mass QTL 30,3.5,0.0008,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),3,66711607,119830094,Rat,n/a,region,qtl 1000,2301414,Kidm37,Kidney mass QTL 37,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,72973445,127023997,Rat,n/a,region,qtl 1000,1302786,Kidm8,Kidney mass QTL 8,28.15,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),5,34402409,79402409,Rat,n/a,region,qtl 1000,634305,Mamtr1,Mammary tumor resistance QTL 1,,0.0001,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,12651967,117554267,Rat,n/a,region,qtl 1000,1600358,Mamtr5,Mammary tumor resistance QTL 5,,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,18847913,63847913,Rat,n/a,region,qtl 1000,1549901,Neudeg2,Neurodegradation QTL 2,4,0,nervous system integrity trait (VT:0010566),mononuclear cell count (CMO:0002119),5,24956212,44747071,Rat,n/a,region,qtl 1000,61462,Niddm10,Non-insulin dependent diabetes mellitus QTL 10,3.9,0.001,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),5,4525738,47978104,Rat,n/a,region,qtl 1000,70212,Niddm25,Non-insulin dependent diabetes mellitus QTL 25,3.54,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),5,1,136640934,Rat,n/a,region,qtl 1000,631841,Niddm39,Non-insulin dependent diabetes mellitus QTL 39,3.36,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,99465522,168732722,Rat,n/a,region,qtl 1000,8552954,Pigfal14,Plasma insulin-like growth factor 1 level QTL 14,9,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),5,21904363,66904363,Rat,n/a,region,qtl 1000,1581546,Pur13,Proteinuria QTL 13,2.93,0.0335,total urine protein amount (VT:0000032),urine protein excretion rate (CMO:0000759),3,81136227,154416635,Rat,n/a,region,qtl 1000,1300111,Rf12,Renal function QTL 12,3.78,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),3,62922868,127023997,Rat,n/a,region,qtl 1000,1331756,Rf34,Renal function QTL 34,4.16275,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal blood flow rate (CMO:0001168),5,1,93273395,Rat,n/a,region,qtl 1000,1331771,Rf35,Renal function QTL 35,4.36965,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal blood flow rate (CMO:0001168),5,1,89432042,Rat,n/a,region,qtl 1000,1581568,Rf53,Renal function QTL 53,,,total urine protein amount (VT:0000032),urine protein excretion rate to body weight ratio (CMO:0001099),3,58204463,170534769,Rat,n/a,region,qtl 1000,1298067,Scl15,Serum cholesterol level QTL 15,4.8,0.001,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,34402409,79402409,Rat,n/a,region,qtl 1000,6903306,Scl35,Serum cholesterol QTL 35,2.6,0.0073,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,29641661,74641661,Rat,n/a,region,qtl 1000,2290448,Scl54,Serum cholesterol level QTL 54,2.93,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,31926122,136640934,Rat,n/a,region,qtl 1000,2312673,Scl63,Serum cholesterol level QTL 63,,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),3,103141814,176418101,Rat,n/a,region,qtl 1000,2312659,Slep7,Serum leptin concentration QTL 7,,0.001,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),3,103141814,176418101,Rat,n/a,region,qtl 1000,1358362,Srcrt2,Stress Responsive Cort QTL 2,2.78,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,39248391,140271184,Rat,n/a,region,qtl 1000,1358353,Srcrtb2,Stress Responsive Cort Basal QTL 2,3.48,0.003,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),5,18847913,76608178,Rat,n/a,region,qtl 1000,6903292,Stl28,Serum triglyceride level QTL 28,2.6,0.0073,blood triglyceride amount (VT:0002644),plasma triglyceride level (CMO:0000548),5,29641661,74641661,Rat,n/a,region,qtl 1000,1578767,Stresp17,Stress response QTL 17,4.3,0.01,blood aldosterone amount (VT:0005346),plasma aldosterone level (CMO:0000551),5,29078899,74078899,Rat,n/a,region,qtl 1000,1578776,Stresp18,Stress response QTL 18,2.9,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),5,29078899,74078899,Rat,n/a,region,qtl 1000,724523,Tsu1,Thymus enlargement suppressive QTL 1,3.84,,thymus mass (VT:0004954),thymus weight to body weight ratio (CMO:0000612),3,51822008,120917851,Rat,n/a,region,qtl 1000,8662454,Vetf3,Vascular elastic tissue fragility QTL 3,27.4,,artery integrity trait (VT:0010639),number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562),5,1666587,71552720,Rat,n/a,region,qtl 1000,8662816,Vetf4,Vascular elastic tissue fragility QTL 4,4,,renal artery integrity trait (VT:0010642),number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563),3,61241033,165369047,Rat,n/a,region,qtl